Short-chain fatty acids–microbiota crosstalk in the coronavirus disease (COVID-19)

The novel coronavirus disease (COVID-19) still remains a major challenge to the health-care systems worldwide, inciting ongoing search for pharmaceutical and non-pharmaceutical interventions which could benefit patients already infected with SARS-CoV-2 or at increased risk thereof. Although SARS-CoV...

Descripción completa

Detalles Bibliográficos
Autores principales: Włodarczyk, Jakub, Czerwiński, Bartłomiej, Fichna, Jakub
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Special Issue: Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513287/
https://www.ncbi.nlm.nih.gov/pubmed/36166147
http://dx.doi.org/10.1007/s43440-022-00415-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513287/
https://www.ncbi.nlm.nih.gov/pubmed/36166147
http://dx.doi.org/10.1007/s43440-022-00415-7

Ejemplares similares